US 12031150
Methods, compositions and kits for increasing genome editing efficiency
granted A61PA61P35/00A61P35/02
Quick answer
US patent 12031150 (Methods, compositions and kits for increasing genome editing efficiency) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00